Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed)

The summary for the Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed): This Funding Opportunity Announcement (FOA) seeks applications from lung transplant clinical centers (CCs) to form a cooperative multi-site Lung Transplant Consortium (LTC). The LTC will support CCs in conducting observational and complementary mechanistic clinical research studies that aim to understand the impact of site-specific lung transplant selection criteria and clinical management strategies on donor lung utilization and/or early post-transplant outcomes such as the development of primary graft dysfunction (PGD) and acute lung allograft dysfunction (ALAD) in recipients. Each CC application must consist of a multidisciplinary investigative team that includes a lung transplant surgeon and a lung transplant pulmonologist, and be comprised of primary and subsites that have a combined annual lung transplant volume of at least 100 transplants. Each CC application should propose hypothesis-driven scientific questions to assess certain donor and/or recipient clinical practices and their impact on donor lung utilization, PGD, ALAD or other relevant short-term outcomes that can be addressed through observational data and/or biospecimen collection and analysis at the sites included in their application. In addition, the CCs will be expected to enroll participants and contribute to a core set of data and biospecimens to be collected across all participating consortium sites through the implementation of a common research protocol under the auspices of a centralized Data Coordinating Center (DCC) and a Steering Committee (SC). By leveraging this shared longitudinal resource, LTC investigators will have the tools to identify and answer additional important research questions involving lung transplantation. This FOA runs in parallel with a separate FOA that invites applications for the LTC Data Coordinating Center, solicited under RFA-HL-22-003.
Federal Grant Title: Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-22-002
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.838
CFDA Descriptions: Information not provided
Current Application Deadline: June 15th, 2021
Original Application Deadline: June 15th, 2021
Posted Date: February 25th, 2021
Creation Date: February 25th, 2021
Archive Date: July 21st, 2021
Total Program Funding:
Maximum Federal Grant Award: $275,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: February 25th, 2021
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Grant Announcement Contact
NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...
Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clin...
Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
Lung Response to Inhaled Highly Toxic Chemicals
Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
More Grants from the National Institutes of Health
INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down s...
NIA MSTEM: Advancing Diversity in Aging Research (ADAR) through Undergraduate Education (R...
Long-Term Effects of Disasters on Healthcare Systems in Populations with Health Disparitie...
Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)
BRAIN Initiative: Scaled reagent resources for brain cell type-specific access across vert... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024